Complete Genome Sequencing, Annotation, and Mutational Profiling of the Novel Clade I Human Mpox Virus, Kamituga Strain.

Franklin Kumbana Mweshi, Gustavo Sganzerla Martinez, David J Kelvin, Patricia Kelvin, Jean Claude Udahemuka, Alyson A Kelvin, Freddy Belesi Siangoli, Justin Bengehya Mbiribindi, Léandre Mutimbwa Mambo, Luis Flores, Bilembo Kitwanda Steeven, Maliyamungu Bubala Nadine, Benjamin Hewins, Ali Toloue Ostadgavahi, Mansi Dutt, Leandre Murhula Masirika, Anuj Kumar

Journal: Journal of infection in developing countries 2024;18(4):600-608

PMID: 38728644

Abstract

INTRODUCTION

Human Mpox (formerly monkeypox) infection is an emerging zoonotic disease caused by the Mpox virus (MPXV). We describe the complete genome annotation, phylogeny, and mutational profile of a novel, sustained Clade I Mpox outbreak in the city of Kamituga in Eastern Democratic Republic of the Congo (DRC).

METHODOLOGY

A cross-sectional, observational, cohort study was performed among patients of all ages admitted to the Kamituga Hospital with Mpox infection symptoms between late September 2023 and late January 2024. DNA was isolated from Mpox swabbed lesions and sequenced followed by phylogenetic analysis, genome annotation, and mutational profiling.

RESULTS

We describe an ongoing Clade I Mpox outbreak in the city of Kamituga, South Kivu Province, Democratic Republic of Congo. Whole-genome sequencing of the viral RNA samples revealed, on average, 201.5 snps, 28 insertions, 81 deletions, 2 indels, 312.5 total variants, 158.3 amino acid changes, 81.66 intergenic variants, 72.16 synonymous mutations, 106 missense variants, 41.16 frameshift variants, and 3.33 inframe deletions across six samples. By assigning mutations at the proteome level for Kamituga MPXV sequences, we observed that seven proteins, namely, C9L (OPG047), I4L (OPG080), L6R (OPG105), A17L (OPG143), A25R (OPG151), A28L (OPG153), and B21R (OPG210) have emerged as hot spot mutations based on the consensuses inframe deletions, frameshift variants, synonymous variants, and amino acids substitutions. Based on the outcome of the annotation, we found a deletion of the D14L (OPG032) gene in all six samples. Following phylogenetic analysis and whole genome assembly, we determined that this cluster of Mpox infections is genetically distinct from previously reported Clade I outbreaks, and thus propose that the Kamituga Mpox outbreak represents a novel subgroup (subgroup VI) of Clade I MPXV.

CONCLUSIONS

Here we report the complete viral genome for the ongoing Clade I Mpox Kamituga outbreak for the first time. This outbreak presents a distinct mutational profile from previously sequenced Clade I MPXV oubtreaks, suggesting that this cluster of infections is a novel subgroup (we term this subgroup VI). These findings underscore the need for ongoing vigilance and continued sequencing of novel Mpox threats in endemic regions.

Copyright (c) 2024 Leandre Murhula Masirika, Anuj Kumar, Mansi Dutt, Ali Toloue Ostadgavahi, Benjamin Hewins, Maliyamungu Bubala Nadine, Bilembo Kitwanda Steeven, Franklin Kumbana Mweshi, Léandre Mutimbwa Mambo, Justin Bengehya Mbiribindi, Freddy Belesi Siangoli, Alyson A Kelvin, Jean Claude Udahemuka, Patricia Kelvin, Luis Flores, David J Kelvin, Gustavo Sganzerla Martinez.

Address: Centre de Recherche en Sciences Naturelles de Lwiro, South Kivu, DS Bukavu, Democratic Republic of the Congo.; Department of Microbiology and Immunology, Canadian Center for Vaccinology (CCfV), Faculty of Medicine, Dalhousie University, Halifax, Canada.; Hospital General de Reference de Kamituga, South Kivu, Democratic Republic of the Congo.; Zone de Santé de Kamituga, South Kivu, Democratic Republic of the Congo.; Division Provinciale de la Santé, South Kivu, Democratic Republic of the Congo.; Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Canada.; Department of Veterinary Medicine, University of Rwanda, Nyagatare, Rwanda.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.